Navigation Links
Hillary Clinton to Return to Work
Date:1/7/2013

MONDAY, Jan. 7 (HealthDay News) -- Secretary of State Hillary Clinton is set to return to work Monday, following treatment for a blood clot in her head.

Clinton, 65, was released from a New York hospital Wednesday evening following three days of treatment with blood-thinning medication for the clot. Her doctors said she should make a full recovery. They believe the clot was linked to a concussion she suffered in December.

On Friday, State Department spokeswoman Victoria Nuland described Clinton's condition after her release as "upbeat" and "raring to go," CNN reported.

However, Nuland added that international travel will not be part of Clinton's agenda "for a little while," following doctors' instructions.

The clot was located outside of the brain, in a vein in the space between the brain and the skull behind Clinton's right ear. The general term for the condition is called cerebral venous thrombosis. Clinton's doctors reported that she did not experience any stroke or neurological injury from the clot.

One expert noted that Clinton will need to be careful in the coming weeks.

"The vast majority of venus sinus thrombosis do not have severe symptoms, and are treated with a combination of hydration and anti-coagulants [blood thinners], which cause the [clot] to slowly dissolve," said Dr. Anders Cohen, chief of neurosurgery and spine surgery at The Brooklyn Hospital Center. "It's important that she gets rest and hydration. Because she'll likely be on blood thinners, she'll have to be careful to avoid falls, which could cause significant bleeding.

"The duration of this medication depends on the size of the thrombosis and Mrs. Clinton's clinical status," Cohen added. "Unless she has a hematological condition that predisposes her to [clots], it is unlikely to reoccur. Most likely, the condition was due to her extremely hectic travel schedule. As a result of the travel, she probably suffered from chronic dehydration, which probably led to her fainting episode last month and caused this thrombosis."

Doctors not involved in Clinton's care said blood thinners are typically used to dissolve clots, and patients may need to be on them for weeks or months.

"Therapy is given anywhere from three to six months or longer, depending on other underlying circumstances or cause of the blood clot," said Dr. Jack Ansell, chairman of the department of medicine at Lenox Hill Hospital in New York City. "In Secretary Clinton's case, one would suspect that trauma from her fall played a role. Dehydration, as reported in the news, may also have been a factor. In some patients, there is an underlying hereditary increased tendency to form blood clots, but I am unaware whether this is a factor. Although there is always a risk of recurrence, the risk is very small and most individuals who experience this problem do not have recurrences. A full recovery is expected."

Clinton had been on a strenuous travel schedule in her role as Secretary of State. According to Bloomberg News, the State Department calculates that she has traveled 949,706 miles and visited 112 countries over 401 days -- about 2,084 hours, or nearly 87 days spent airborne.

More information

There's more on blood clots at the U.S. National Library of Medicine.

SOURCES: Anders Cohen, D.O., chief, neurosurgery and spine surgery, The Brooklyn Hospital Center; Jack Ansell, M.D., chairman, department of medicine, Lenox Hill Hospital, New York City; CNN; Bloomberg News


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hillary Clinton Plans to Return to Work Next Week
2. Hillary Clinton Released From NYC Hospital
3. Hillary Clintons Hospital Care for Clot Continues
4. Hillary Clinton Has Blood Clot in Head, Full Recovery Expected
5. AuDNet Pushes for Professional Hearing Tests for All Troops Returning from the Middle East.
6. MCG faculty member, former hostage returns to Kuwait as Fulbright Scholar
7. Chemo May Extend Survival After Breast Cancers Return
8. Power Slowly Returns to Much of Northeast After Sandy
9. Johns Hopkins researchers return blood cells to stem cell state
10. Workers Counseled on Back Pain Return to Job Sooner
11. Smoking Tied to Risk for Hepatitis Return After Liver Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hillary Clinton to Return to Work 
(Date:12/7/2016)... , ... December 07, 2016 , ... ... Medicine will have the unique opportunity to get hands-on experience in an ... school students an immersive experience to gain invaluable, real-life medical skills that are ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... drug in their bodies, a researcher at the Icahn School of Medicine at ... , The study found that when young children are exposed to secondhand marijuana ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... a women growing up with a schizophrenic mother in a unique, personal perspective ... who specializes in treating trauma and addictive disorders at her private psychotherapy practice. ...
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any lab to ... analyzed data. The team at Beckman Coulter has designed Kaluza, templates with advanced analytical ... the need to operate in a GLP (Good Laboratory Practice) fashion. , With features ...
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein ... according to a study appearing online in the journal Radiology. , Heart disease and ... increase significantly due to the rapidly aging population. Damage to both organs often occurs ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Pennsylvania Physician General ... Drug and Alcohol Programs Gary Tennis ... medications, known as benzodiazepines, developed with the help ... are medications that are frequently prescribed for anxiety ... are used with opioid pain medications, benzodiazepines pose ...
(Date:12/8/2016)... -- A new study by a pair of Geisinger Health ... to treat chronic pain is not only ineffective, it ... including death. Palliative care physicians Mellar ... M.D., authored the study which provides a review of ... was published in the December 2016 edition of Current ...
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
Breaking Medicine Technology: